460 filings
SC 13G/A
Advantech Capital L.P.
20 Mar 24
SINOVAC BIOTECH / Advantech Capital ownership change
7:33am
SC TO-T/A
Alternative Liquidity Index LP
15 Mar 24
Third party tender offer statement (amended)
6:18pm
8-A12B/A
SVA
Sinovac Biotech, Ltd.
21 Feb 24
Registration of securities on exchange (amended)
6:09am
6-K
SVA
Sinovac Biotech, Ltd.
21 Feb 24
Current report (foreign)
6:02am
SC TO-T/A
Alternative Liquidity Index LP
2 Feb 24
Third party tender offer statement (amended)
11:19am
SC 14D9
7ckrr27ne uv5
18 Jan 24
Tender offer solicitation
7:13am
SC TO-T
d78dgrutwdt
8 Jan 24
Third party tender offer statement
4:46pm
SC 13D/A
uys30v2b9a0eeq 7ko
4 Dec 23
SINOVAC BIOTECH / SAIF Partners IV ownership change
6:01am
UPLOAD
l72fn
10 Oct 23
Letter from SEC
12:00am
CORRESP
2s3w8 63qm
5 Oct 23
Correspondence with SEC
12:00am
SC TO-T/A
nufqpr1pepg5obje9qih
3 Oct 23
Third party tender offer statement (amended)
9:39am
SC 13D/A
01nw hy85v9lp8
15 Sep 23
SINOVAC BIOTECH / SAIF Partners IV ownership change
8:59am
6-K
j8rn7zltr 2d50l2
11 Sep 23
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
6:16am
UPLOAD
xuaget9
8 Sep 23
Letter from SEC
12:00am
SC 14D9
is9ymsb1
5 Sep 23
Tender offer solicitation
7:04am
CORRESP
ozxbtyg18 eamh
1 Sep 23
Correspondence with SEC
12:00am
6-K
mnx7nnp5mc moc00q52
29 Aug 23
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
6:05am
6-K
8r6b8z10ve9een5q
28 Aug 23
Sinovac Announces Change of Legal Representative of Sinovac Beijing
9:12am
SC TO-T
8ci1pkc7lrqalyukdp
24 Aug 23
Third party tender offer statement
6:10pm
6-K
40surgfejc80s
15 Aug 23
SINOVAC Reports Unaudited First Half of 2023 Financial Results
6:27am